Cargando…

CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension: A Retrospective Study

Background and Aims: To evaluate the prevalence and significance of elevated cancer antigen-125 (CA-125) levels in patients with cirrhosis being treated in a tertiary care liver center and its correlation with objective markers of disease severity. Methods: We retrospectively reviewed medical record...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edula, Raja GR, Muthukuru, Sujit, Moroianu, Serban, Wang, Yucai, Lingiah, Vivek, Fung, Phoenix, Pyrsopoulos, Nikolaos T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160305/ https://www.ncbi.nlm.nih.gov/pubmed/30271734 http://dx.doi.org/10.14218/JCTH.2017.00070

Ejemplares similares

CA-125 Significance in Cirrhosis and Correlation with Disease Severity and Portal Hypertension
por: Collazos, Julio
Publicado: (2018)

Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital
por: Lingiah, Vivek A., et al.
Publicado: (2021)

Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect
por: Shah, Jamil, et al.
Publicado: (2019)

Acute Liver Injury due to Severe Epstein-Barr Virus Infection
por: Shah, Jamil, et al.
Publicado: (2020)

Emerging concepts in alcoholic hepatitis
por: Fung, Phoenix, et al.
Publicado: (2017)

Emricasan (IDN‐6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
por: Garcia‐Tsao, Guadalupe, et al.
Publicado: (2018)

Liver Transplantation Beyond Milan Criteria
por: Lingiah, Vivek A, et al.
Publicado: (2020)

Acute Liver Injury as a Manifestation of Secondary Syphilis
por: Shah, Jamil, et al.
Publicado: (2021)

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
por: Edula, Raja GR, et al.
Publicado: (2009)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis
por: Wang, Yizhe, et al.
Publicado: (2022)

CA 125 concentration in portal blood as a predictor of resectability in pancreatic tumor
por: Szwedziak, Krzysztof, et al.
Publicado: (2013)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes
por: Liu, Furong, et al.
Publicado: (2020)

Significance of the serum CA-125 level in intrauterine insemination cycles
por: Choe, Seung Ah, et al.
Publicado: (2011)

Clinical Significance of Serum CA-125 in Korean Females with Ascites
por: Bae, So Young, et al.
Publicado: (2013)

Clinical significance of serum CA125 in diffuse malignant mesothelioma
por: Cheng, Xu, et al.
Publicado: (2016)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models
por: Chang, Johannes, et al.
Publicado: (2021)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Portal Hypertensive Polyps as Gastroscopic Finding in Liver Cirrhosis
por: Topal, Firdevs, et al.
Publicado: (2020)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2022)

Improved Outcomes Following Hepatocellular Carcinoma (HCC) Diagnosis in Patients Screened for HCC in a Large Academic Liver Center versus Patients Identified in the Community
por: Okoronkwo, Nneoma, et al.
Publicado: (2017)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)

AN EXPERIMENTAL STUDY INTO THE CAUSE OF THE INCREASED PORTAL PRESSURE IN PORTAL CIRRHOSIS
por: Herrick, Frederick C.
Publicado: (1907)

Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2022)

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
por: Kakimoto, Soichiro, et al.
Publicado: (2021)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

The Impact of Cirrhosis on Outcomes of Patients Admitted With Diabetic Ketoacidosis: A Nationwide Study
por: Mansour, Mahmoud M, et al.
Publicado: (2022)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

Significant elevation in serum CA 125 and CA 19-9 levels with torsion of the hydrosalpinx in a postmenopausal woman
por: Kim, Ji Hye, et al.
Publicado: (2017)

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
por: Fang, Tianyi, et al.
Publicado: (2019)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gpcdrvq3jd3nt012sstjt7rc10